This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42623087
rdf:type
wikibase:Item
schema:description
2004年論文 vetenskaplig artikel wetenschappelijk artikel 2004年论文 επιστημονικό άρθρο article scientifique artigo científico 2004年论文 научни чланак ফেব্রুয়ারি ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2004年の論文 სამეცნიერო სტატია artigo científico tudományos cikk articol științific teaduslik artikkel 2004年論文 artykuł naukowy vědecký článek artikull shkencor vitenskapelig artikkel מאמר מדעי 2004年論文 videnskabelig artikel 2004년 논문 bilimsel makale naučni članak artigo científico 2004年論文 bài báo khoa học article científic 2004年论文 научна статия vedecký článok مقالة علمية نشرت في فبراير 2004 scientific article published on February 2004 vitskapeleg artikkel мақолаи илмӣ 2004年论文 article scientific 2004年論文 scienca artikolo artículu científicu espublizáu en 2004 artikulong pang-agham scientific article published on February 2004 artikel ilmiah บทความทางวิทยาศาสตร์ articolo scientifico 2004年论文 научни чланак wissenschaftlicher Artikel 2004 nî lūn-bûn artículo científico publicado en 2004 tieteellinen artikkeli наукова стаття, опублікована в лютому 2004 2004年论文 научная статья scientific article published on February 2004
p:P577
wds:Q42623087-A170D346-4F4C-411D-BDC5-7790F0653E73
wdt:P577
2004-02-01T00:00:00Z
p:P407
wds:Q42623087-F53F7BC9-69D7-4E29-99B3-18629F220F5F
wdt:P407
wd:Q1860
p:P2860
wds:Q42623087-F0D79E5B-ADCB-40ED-9EDA-1550FE798AED wds:Q42623087-DE82B9F9-BD44-4DA6-BCD9-995B73EF6F5F wds:Q42623087-CFAB76D4-A0AE-4AC7-A96B-5E1F5BE92BC3 wds:Q42623087-D560C3F2-9CE8-4100-9CC4-7D90F5928F97 wds:Q42623087-D7F9BED8-6E3F-4AF9-BF3F-0A5EBF87CE3B wds:Q42623087-A634418D-2A7C-4269-848A-CE5736D4FA42 wds:Q42623087-B58BF6B0-D399-4322-9557-4EDCB20B3EF7 wds:Q42623087-71F54F1D-2094-4C94-8734-B35EE170DC4A wds:Q42623087-7FC67922-E674-4122-881D-F3B5E13358C5 wds:Q42623087-922F4287-779E-49F3-A17B-D981AFCE734C wds:Q42623087-95533728-ADE8-4999-BFB8-D1BE00E49722 wds:Q42623087-48BB589D-921A-4AFC-83E6-127039F8D719 wds:Q42623087-590F86AB-2069-4C6B-9FB5-0887A8971A51 wds:Q42623087-10C107C3-32C5-4D11-B471-33E665A1DD63 wds:Q42623087-16643A73-F861-4A4E-B8C2-0C1500BD2B09
wdt:P2860
wd:Q41526091 wd:Q44568299 wd:Q43723681 wd:Q39467140 wd:Q34485941 wd:Q36053927 wd:Q33707148 wd:Q43988923 wd:Q45939217 wd:Q34409983 wd:Q42786268 wd:Q40743537 wd:Q70736037 wd:Q44429703 wd:Q44877620
p:P2093
wds:Q42623087-D0FB87F8-EA5A-4E09-8F47-A45ECAD2EC26 wds:Q42623087-E84708C0-D052-4D65-8559-DB6FCBE55B66 wds:Q42623087-DD4E1816-2A2A-4D07-B1D1-361D0EFC05A8 wds:Q42623087-2D8E0E5F-26FE-4A6D-A588-7C8EF112DE63 wds:Q42623087-29A7B76E-4E7A-4084-AADC-B94B97EE6260 wds:Q42623087-44B5824B-2DB1-41CF-9AA4-ECC558FF80C3 wds:Q42623087-2F0D5EB9-93B0-42CE-A4F4-56ABD925DB6E
wdt:P2093
JoséAntonio Sacristán Carmen Turbí Antonio Torrijos Fernando Marín Roberto Miguélez Juan Carlos Acebes Jenaro Graña
rdfs:label
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study
skos:prefLabel
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study
schema:name
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study
p:P50
wds:Q42623087-0CC45E95-0B98-40F7-8BEE-D8DA9C1D09F0
wdt:P50
wd:Q42186933
p:P1476
wds:Q42623087-F5B18AA9-3993-4A0D-BF6B-059D5B4D9FDC
wdt:P1476
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study
p:P304
wds:Q42623087-EB020E30-F9CE-422C-A7F1-9EC48DF4E1DD
wdt:P304
245-256
p:P31
wds:Q42623087-5C0B5BDE-190D-4336-920E-A39741F0C8CB
wdt:P31
wd:Q13442814
p:P921
wds:Q42623087-2FC0851C-1E9B-4D32-8350-A57249C3AE28 wds:Q42623087-CAB5BB29-DAAD-4CD0-8609-D19D295D3872
wdt:P921
wd:Q55950294 wd:Q165328
p:P698
wds:Q42623087-6F8149CD-6314-4692-898F-0749B35B2A27
wdtn:P698
n12:15038947
wdt:P698
15038947
p:P1433
wds:Q42623087-2CB68929-A872-4996-B6B1-4CF1A9AEB726
wdt:P1433
wd:Q15716601
p:P433
wds:Q42623087-3B42D238-8F7C-40A7-A981-0AFA4FB41AA2
p:P478
wds:Q42623087-0FFC0E5F-7AB1-4AC8-B202-090D03ED7D33
wdt:P433
2
wdt:P478
26
p:P356
wds:Q42623087-23398668-1B67-41CA-ADD9-338A8D68BAF5
wdtn:P356
n10:S0149-2918(04)90023-9
wdt:P356
10.1016/S0149-2918(04)90023-9